Literature DB >> 6432498

Effects of very low doses of atropine on basal acid and pepsin secretion, gastrin, and heart rate in normals and DU.

B I Hirschowitz, E Molina, L Ou Tim, C Helman.   

Abstract

Muscarinic mechanisms in basal acid and pepsin secretion in man were quantitated by graded intravenous doses of atropine (1-16 micrograms/kg). Secretion was dose-responsively inhibited in six healthy controls. For the mean dose response, maximum inhibition (Imax) was 100%, and D50 (dose inhibiting 50%) was 0.31 +/- 0.06 and 0.93 +/- 0.13 micrograms/kg, respectively, for acid and pepsin. In 24 patients with duodenal ulcer (DU), calculated Imax was also 100%, and D50S were 1.2 +/- 0.27 and 1.7 +/- 0.3 micrograms/kg, respectively. The low D50 values and the 100% calculated maximum inhibition indicated that in both groups basal secretion was largely or completely cholinergic dependent. We also found that atropine raised heart rate in controls by 44 +/- 1 beats per min (bpm) (D50 = 6 +/- 1.1 micrograms/kg), while the mean maximum increase in DU was only 23 +/- 2 bpm (P less than 0.01) with (D50 = 5.3 +/- 1.0 micrograms/kg (NS)). In DU atropine increased fasting serum gastrin from 62 to 82 pg/ml (P less than 0.05); the increase in normals from 32 to 38 pg/ml was not significant. Thus, while both normals and DU exhibited the same qualitative responses to muscarinic receptor antagonism by atropine with respect to gastric secretion, gastrin levels, and heart rate, there were quantitative differences in all three parameters.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432498     DOI: 10.1007/bf01318420

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Optimal effective dose of anticholinergic drug in peptic ulcer therapy.

Authors:  D C SUN; H SHAY
Journal:  AMA Arch Intern Med       Date:  1956-04

3.  Atropine inhibition of insulin-, histamine-, and pentagastrin-stimulated gastric electrolyte and pepsin secretion in the dog.

Authors:  B I Hirschowitz; G Sachs
Journal:  Gastroenterology       Date:  1969-04       Impact factor: 22.682

4.  Kinetics of atropine inhibition of histamine-stimulated gastric secretion in the dog.

Authors:  B I Hirschowitz; G Hutchison; G Sachs
Journal:  Am J Physiol       Date:  1972-05

5.  Two models of gastric H, Na, K, and Cl secretion in the dog using histamine and pentagastrin.

Authors:  G A Hutchison; B I Hirschowitz
Journal:  Am J Physiol       Date:  1969-03

Review 6.  Anticholinergics for peptic ulcer--a renaissance?

Authors:  W Londong
Journal:  Hepatogastroenterology       Date:  1982-02

7.  Kinetics of atropine inhibition of pentagastrin-stimulated H+, electrolyte, and pepsin secretion in the dog.

Authors:  B I Hirschowitz; G A Hutchison
Journal:  Am J Dig Dis       Date:  1977-02

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation.

Authors:  S J Konturek; N Kwiecien; W Obtulowicz; E Mikos; E Sito; J Oleksy; T Popiela
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

10.  Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal.

Authors:  V Schusdziarra; D Rouiller; A Pietri; V Harris; E Zyznar; J M Conlon; R H Unger
Journal:  Am J Physiol       Date:  1979-12
View more
  2 in total

1.  Vagal effects on acid and pepsin secretion and serum gastrin in duodenal ulcer and controls.

Authors:  B I Hirschowitz; J Groarke
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

2.  Gastric acid secretion and gastrin release in the baboon.

Authors:  K Lakhoo; D Parekh; H H Lawson; G Rogers; L A Van der Walt; S Hunter
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.